Navigation Links
Mission Pharmacal Launches New Vitamin B6-Rich Prescription Prenatal Vitamin, CitraNatal(R) B-Calm

SAN ANTONIO, March 1 /PRNewswire/ -- Mission Pharmacal announced today the addition of CitraNatal® B-Calm to its CitraNatal® family of prescription prenatal vitamins.  CitraNatal B-Calm offers gentle prenatal nutrition plus the benefits of additional vitamin B6, which supplements a woman's own defense against severe pregnancy-related nausea and vomiting.  Emerging science suggests that vitamin B6 supplementation can be beneficial for pregnant women who suffer with severe nausea during pregnancy.

"For many women, pregnancy-related nausea and vomiting can be a serious concern," said Neill Walsdorf, Jr., president of Mission Pharmacal.  "We are pleased to offer women a prenatal vitamin option that may help provide some relief during their pregnancies, while providing the quality and comfort women have come to trust with the CitraNatal name."

As many as 85 percent of pregnant women may experience nausea and up to half may experience vomiting early during their pregnancies.  With 75 mg of vitamin B6 dosed over 24 hours, CitraNatal B-Calm may be used in conjunction with a physician prescribed regimen to help minimize these symptoms.

CitraNatal B-Calm contains 25 mg of vitamin B6 in the multivitamin and two 25 mg vitamin B6 supplements to be taken at eight-hour intervals.  Vitamin B6 is recommended by The American College of Obstetricians and Gynecologists as a safe and effective first-line supplementation for pregnancy-related nausea and vomiting.  The multivitamin tablet also contains a signature CitraNatal formula with gentle ingredients for mom and strong nutrition for baby, including folic acid, calcium citrate and carbonyl iron.

In addition, Mission Pharmacal is currently working to add a recently acquired, dual-iron technology into the existing CitraNatal family of prescription prenatal vitamins, including CitraNatal B-Calm, as well as Ferralet 90, a prescription oral iron supplement for the treatment of iron deficiency anemia.  The new technology is a varied release of carbonyl iron and ferrous gluconate that combines the quick uptake of a ferrous salt and the more prolonged absorption in the body of carbonyl iron.

Women who are pregnant or planning to conceive should consult their healthcare providers prior to beginning any prenatal vitamin regimen.

About the CitraNatal® Line

CitraNatal is marketed by Mission Pharmacal Company based in San Antonio, Texas.  CitraNatal vitamins are specially formulated for the many women who require nutritional support prior to conception, throughout pregnancy, and during the postnatal period.  The plant-derived DHA found in several CitraNatal products is produced exclusively by Martek Biosciences Corporation based in Columbia, Maryland.

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 60 years, the company has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them.  Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products.  For more information, visit or

SOURCE Mission Pharmacal

Back to top



SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Game Commission Announces EHD Confirmed in Fayette County
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Post Your Comments:
(Date:11/24/2015)... Nueva York , 24 de noviembre ... fabricante del Avery Breathing Pacemaker System, se complace ... MD; Ph.D. como consultor clínico. ... --> Foto -   ... doctor Jonzon es un fisiólogo y consultor en ...
(Date:11/24/2015)... 24, 2015 Avery Biomedical Devices (ABD), manufacturer ... announce the appointment of Anders Jonzon , MD; ... Dr. Jonzon is a Physiologist ... Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... a fellow at the Cardiovascular Institute (UCSF). His research ...
(Date:11/24/2015)... November 24, 2015 F1000Workspace - ... - since it was launched just six months ago. ... and authoring platform for scientists - since it was launched ... have been loaded on to F1000Workspace - a ... since it was launched just six months ago. ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted general ... of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many ... the doctor uses other traditional cutting tools, such as the scalpel and high-speed drill, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article published November 12th ... which patients are or are not eligible for bariatric surgery. The article explains that ... are more than 100 pounds overweight, or have a BMI of 35 and over ...
(Date:11/24/2015)... ... 2015 , ... It takes only three to five seconds to make a ... first impression be positive and reflects business values. If a client starts with a ... to return. They will also share their thoughts about a business with others, which ...
(Date:11/24/2015)... ... 2015 , ... Cancer patients, survivors, caregivers, family members and ... taping of the next CURE Connections® video series on Saturday, Dec. ... at Georgetown University Hotel & Conference Center in Washington, D.C. , CURE Connections, ...
(Date:11/24/2015)... Danbury, CT (PRWEB) , ... November 24, 2015 , ... ... Network (WCHN) today announced an innovative study designed to yield insights into how to ... potential development of biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic ...
Breaking Medicine News(10 mins):